As this happened, The Benchmark Company downgraded its AbCellera Biologics Inc [ABCL] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including The Benchmark Company’s analysts, who increased its forecast for the stock in late February from “a Hold” to “a Buy”. KeyBanc Capital Markets began covering ABCL with “an Overweight” recommendation on December 05, 2023. The Benchmark Company revised its rating on November 06, 2023. It rated ABCL as “a Hold” which previously was an “a Buy”.
Price Performance Review of ABCL
On Tuesday, AbCellera Biologics Inc [NASDAQ:ABCL] saw its stock fall -0.41% to $2.43. Over the last five days, the stock has gained 25.91%. AbCellera Biologics Inc shares have fallen nearly -17.06% since the year began. Nevertheless, the stocks have fallen -44.01% over the past one year. While a 52-week high of $4.34 was reached on 01/22/25, a 52-week low of $1.89 was recorded on 04/07/25. SMA at 50 days reached $2.60, while 200 days put it at $2.77.
Levels Of Support And Resistance For ABCL Stock
The 24-hour chart illustrates a support level at 2.35, which if violated will result in even more drops to 2.26. On the upside, there is a resistance level at 2.51. A further resistance level may holdings at 2.58. The Relative Strength Index (RSI) on the 14-day chart is 53.00, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.22, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 11.48%. Stochastics %K at 82.10% indicates the stock is a selling.
How much short interest is there in AbCellera Biologics Inc?
A steep rise in short interest was recorded in AbCellera Biologics Inc stocks on 2025-03-31, growing by 3.73 million shares to a total of 23.62 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 19.9 million shares. There was a rise of 15.77%, which implies that there is a positive sentiment for the stock.
